Table 1.
Treatment | Control | EGCG2 | EGCG10 | EGCG50 | tBHP0.25 | EGCG2 + t-BHP0.25 | EGCG10 + tBHP0.25 | EGCG50 + tBHP0.25 |
---|---|---|---|---|---|---|---|---|
Mit | 11.6 ± 1.3 | 10.5 ± 1.1 | 10.0 ± 0.9 | 7.0 ± 1.1∗∗∗ | 6.3 ± 0.9∗∗∗ | 5.8 ± 0.7∗∗∗,+++ | 5.9 ± 0.2∗∗∗,+++ | 4.4 ± 0.3∗∗∗,+++,# |
Hep | 5.5 ± 1.1 | 5.1 ± 1.0 | 5.2 ± 0.8 | 4.2 ± 0.6∗ | 3.3 ± 0.5∗∗∗ | 3.2 ± 0.6∗∗∗,+++ | 3.3 ± 0.6∗∗∗,+++ | 2.7 ± 0.5∗∗∗,+ |
1Data are expressed as the mean ± standard deviation. Mit = mitochondria and Hep = permeabilized hepatocytes. Concentration of tBHP is shown in mmol/L and that of EGCG in μmol/L; ∗ versus control, + versus corresponding EGCG, and # versus tBHP alone; p < 0.05, <0.01, or <0.001 for one, two, or three symbols, respectively; n = 6–10.